Key Attributes of a Reusable Insulin Pen Injector That Balances Optimal Insulin Delivery With Sustainability. [PDF]
Wernersson AS +3 more
europepmc +1 more source
Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol. [PDF]
Rabbone I +10 more
europepmc +1 more source
Emerging perspectives on once-weekly insulins in type 1 and type 2 diabetes: a mini-review. [PDF]
Denimal D.
europepmc +1 more source
A Case of Insulin Edema Syndrome Improved by Weekly Insulin. [PDF]
Desgagnés N +3 more
europepmc +1 more source
Revolutionizing Diabetes Care: From Tech to Therapeutics. [PDF]
Akturk HK, Waterman LA, Cobry EC.
europepmc +1 more source
Impact of structure and formulation changes on the function of insulin products. [PDF]
Yang Y +4 more
europepmc +1 more source
Switch from premixed insulin analogue to degludec-liraglutide combination: a CGM study. [PDF]
Kravos Tramšek NA, Koceva A, Krajnc M.
europepmc +1 more source
Degludec/Liraglutid-Fixkombination als Therapiealternative [PDF]
openaire +1 more source
Once-Weekly Insulin Efsitora Alfa Versus Once Daily Insulin in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis. [PDF]
Mehmood H +13 more
europepmc +1 more source
Comparative Effectiveness of Switching From First-Generation Basal Insulins to Either Glargine 300 U/mL or Degludec 100 U/mL in Children and Adolescents With Type 1 Diabetes: Results From the ISPED CARD Clinical Registry. [PDF]
Rabbone I +8 more
europepmc +1 more source

